Menu

JODAS HAS EVOLVED SIGNIFICANTLY, AS A GENERICS NEW GENERATION PHARMACEUTICAL COMPANY.

  • 2006 - Founded the organization in India
  • 2006 - Started a subsidiary and regional office in Russia
  • 2007 - 3 molecules of anti-infectives commercialized in Russia
  • 2010 - 14 molecules of anti-infectives commercialized in Russia
  • 2010 - Launched Oncology products in Russia
  • 2011 - Conducted BE study for Temozolomide caps in Russia
  • 2012 - Achieved 38 SKUs commercialization in Russia
  • 2012 - Conducted BE study Gefitinib tabs in Russia
  • 2012 - Laid foundation for the green field Global facility at Hyderabad, India.
  • 2013 - Launched Cardiac critical care and Radio Contrast Media products
  • 2013 - Conducted BE study of Enoxaparin Inj in Russia
  • 2014 - Completed 43 BE studies in Russia
  • 2014 - Successfully marked our foot print in more than 50 cities in Russia
  • 2014 - Achieved significant market share with 7mn Injectables commercialized
  • 2014 - Achieved 68 Products registration in Russia
  • 2015 - Completed Phase –I (Cephalosporin’s unit) of our Global facility in Hyderabad, India.